PROCEPT BioRobotics logo

PROCEPT BioRoboticsNASDAQ: PRCT

Profile

Sector:

Healthcare

Country:

United States

IPO:

15 September 2021

Next earnings report:

27 February 2025

Last dividends:

N/A

Next dividends:

N/A
$4.92 B
-8%vs. 3y high
89%vs. sector
-vs. 3y high
-vs. sector
-8%vs. 3y high
97%vs. sector
-61%vs. 3y high
88%vs. sector

Price

after hours | Thu, 21 Nov 2024 00:55:28 GMT
$91.00$0.00(0.00%)

Dividend

No data over the past 3 years
$58.37 M$66.77 M
$58.37 M-$20.97 M

Analysts recommendations

Institutional Ownership

PRCT Latest News

Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice
zacks.com07 November 2024 Sentiment: POSITIVE

Does PROCEPT BioRobotics Corporation (PRCT) have what it takes to be a top stock pick for momentum investors? Let's find out.

All You Need to Know About PROCEPT BioRobotics (PRCT) Rating Upgrade to Strong Buy
zacks.com29 October 2024 Sentiment: POSITIVE

PROCEPT BioRobotics (PRCT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
globenewswire.com28 October 2024 Sentiment: NEUTRAL

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the commencement of an underwritten public offering of $175,000,000 of shares of its common stock. A selling stockholder also expects to grant the underwriters a 30-day option to purchase up to an additional $26,250,000 of shares of the Company's common stock. PROCEPT BioRobotics will not receive any proceeds from any sale of shares by the selling stockholder. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential
benzinga.com28 October 2024 Sentiment: POSITIVE

PROCEPT BioRobotics PRCT stock is trading on Monday after the company released better-than-expected third-quarter earnings.

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript
seekingalpha.com28 October 2024 Sentiment: NEUTRAL

PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q3 2024 Earnings Conference Call October 28, 2024 8:00 AM ET Company Participants Matt Bacso - Vice President, Investor Relations Reza Zadno - Chief Executive Officer Sham Shiblaq - Chief Commercial Officer Kevin Waters - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Securities Brandon Vasquez - William Blair Richard Newitter - Truist Josh Jennings - TD Cowen Chris Pasquale - Nephron Research Ryan Zimmerman - BTIG Brett Gasaway - Leerink Partners Operator Good morning and welcome to PROCEPT BioRobotics Third Quarter 2024 Earnings Conference Call. At this time all participants' are in a listen-only mode.

PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates
zacks.com28 October 2024 Sentiment: POSITIVE

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.51 per share a year ago.

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
globenewswire.com28 October 2024 Sentiment: POSITIVE

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2024.

Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround
zacks.com25 October 2024 Sentiment: POSITIVE

PROCEPT BioRobotics (PRCT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
zacks.com21 October 2024 Sentiment: POSITIVE

PROCEPT BioRobotics (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRCT Stock Rises on FDA's Nod to Initiate Study on Prostate Cancer
zacks.com08 October 2024 Sentiment: POSITIVE

PROCEPT BioRobotics receives FDA's approval to begin a pivotal randomized clinical study to assess the use of Aquablation therapy in treating prostate cancer patients.

  • 1(current)
  • 2

What type of business is PROCEPT BioRobotics?

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

What sector is PROCEPT BioRobotics in?

PROCEPT BioRobotics is in the Healthcare sector

What industry is PROCEPT BioRobotics in?

PROCEPT BioRobotics is in the Medical Devices industry

What country is PROCEPT BioRobotics from?

PROCEPT BioRobotics is headquartered in United States

When did PROCEPT BioRobotics go public?

PROCEPT BioRobotics initial public offering (IPO) was on 15 September 2021

What is PROCEPT BioRobotics website?

https://www.procept-biorobotics.com

Is PROCEPT BioRobotics in the S&P 500?

No, PROCEPT BioRobotics is not included in the S&P 500 index

Is PROCEPT BioRobotics in the NASDAQ 100?

No, PROCEPT BioRobotics is not included in the NASDAQ 100 index

Is PROCEPT BioRobotics in the Dow Jones?

No, PROCEPT BioRobotics is not included in the Dow Jones index

When was PROCEPT BioRobotics the previous earnings report?

No data

When does PROCEPT BioRobotics earnings report?

The next expected earnings date for PROCEPT BioRobotics is 27 February 2025